The NHS will not be able to deliver new draft guidelines on kidney cancer without major investment in diagnostic procedures and treatments, a leading expert has warned.
This week the National Institute for Health and Care Excellence (NICE) published new draft guidance recommending that more people with suspected kidney cancer should have a biopsy to help confirm their diagnosis sooner.1
But Pat Price, chair of Radiotherapy UK, warned that while the “long awaited” updated guidance was welcome, successfully implementing it may be “wishful thinking” because of a lack of funding and excessive NHS bureaucracy.
“There is a disconnect. NICE is great at doing best practice, but is the NHS able to deliver anymore?” said Price, a surgery and cancer professor at Imperial College London. “NHS England cannot deliver on evidence based medicine …
